Basit öğe kaydını göster

dc.contributor.authorGokcay, Asena
dc.contributor.authorIsik, Metin
dc.contributor.authorCalguneri, Meral
dc.date.accessioned2019-12-10T11:20:17Z
dc.date.available2019-12-10T11:20:17Z
dc.date.issued2012
dc.identifier.issn1302-0234
dc.identifier.urihttps://doi.org/10.4274/tftr.55706
dc.identifier.urihttp://hdl.handle.net/11655/15298
dc.description.abstractPrimary pulmonary amyloidosis is a localized type of amyloidosis which usually presents with parenchymal nodules, diffuse alveolar damage, or submucosal deposits in the airways. Polymyozitis is an inflammatory autoimmune myopathy characterized by symmetric weakness of the limb girdle and anterior neck muscles. Nearly 80-90% of cases with polymyositis are successfully treated with steroid and cyclophosphamide combination therapies. Polymyozitis also cause secondary interstitial lung disease and the radiological findings of these two diseases may not be easily discriminated from each other. Turk J Phys Med Rehab 2072;58:159-61.
dc.language.isoen
dc.publisherAves
dc.relation.isversionof10.4274/tftr.55706
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectRehabilitation
dc.titlePulmonary Amyloidosis Mimicking Interstitial Lung Disease in A Patient with Polymyozitis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalTurkiye Fiziksel Tip Ve Rehabilitasyon Dergisi-Turkish Journal Of Physical Medicine And Rehabilitation
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume58
dc.identifier.issue2
dc.identifier.startpage159
dc.identifier.endpage161
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster